Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

ASCO-GU – prostate cancer PARPS move to the front line
EP Vantage
Sun, 02/20/22 - 11:44 am
Tags:
prostate cancer, ASCO-GU, PARP inhibitors, Lynparza, Zejula, Rubraca, Talzenna, biomarkers, AstraZeneca, Merck, GSK, JNJ, Clovis Oncology
AstraZeneca scores another industry victory over the federal government in 340B litigation
Endpoints
Thu, 02/17/22 - 11:23 pm
Tags:
AstraZeneca, Delaware, 340B, legal
Covid infects biopharma’s biggest sellers
EP Vantage
Thu, 02/17/22 - 10:45 am
Tags:
Pfizer, AstraZeneca, vaccines, COVID-19, Roche
AstraZeneca/Merck come out of ASCO GU with a big win over J&J in battle over prostate cancer franchises
Endpoints
Tue, 02/15/22 - 11:31 pm
Tags:
AstraZeneca, Merck, JNJ, ASCO, prostate cancer, Lynparza
AstraZeneca pledges more Evusheld doses to US, bringing its antibody supply deal to $855M
Fierce Pharma
Mon, 02/14/22 - 10:53 am
Tags:
AstraZeneca, COVID-19, Evushield, HHS
AstraZeneca dumps late-phase, next-gen COVID-19 vaccine, calling time on a beta player in an omicron world
Fierce Biotech
Thu, 02/10/22 - 10:46 am
Tags:
AstraZeneca, COVID-19, vaccines, AZD2816, Vaxzevria
Pascal Soriot: AstraZeneca 'on track' to hit big $40B goal, capping years-long turnaround campaign
Endpoints
Thu, 02/10/22 - 10:42 am
Tags:
AstraZeneca, earnings, vaccines, COVID-19, Pascal Soriot, Pharma CEOs
Are Intranasal Sprays The Next $36 Billion Trend in Vaccine Stocks?
Motley Fool
Tue, 02/8/22 - 09:56 am
Tags:
vaccines, AstraZeneca, intranasal vaccines
AstraZeneca Will Ax Its U.S. Workers’ Pension Plan This Year
Bloomberg
Mon, 02/7/22 - 11:28 pm
Tags:
AstraZeneca, pensions, employees, employee benefits
Watch out, AstraZeneca: UCB uncorks late-stage success for $2.1B Soliris rival
Endpoints
Fri, 02/4/22 - 11:11 am
Tags:
UCB Pharma, clinical trials, myasthenia gravis, AstraZeneca, Soliris, zilucoplan
AstraZeneca reveals insurance fraud probe in China as officials say they've made criminal arrests
Fierce Pharma
Mon, 01/31/22 - 10:43 am
Tags:
AstraZeneca, China, fraud, insurance
ASCO-GI – immuno-oncology makes progress in liver cancer
EP Vantage
Fri, 01/21/22 - 10:37 am
Tags:
AstraZeneca, Imfinizi, tremelimumab, ASCO-GI, liver cancer
COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ
Fierce Pharma
Thu, 01/20/22 - 11:23 pm
Tags:
Pfizer, Moderna Therapeutics, JNJ, AstraZeneca, COVID-19, vaccines, reputation
AstraZeneca bets $75M on Scorpion’s precision approach to tough cancer targets
MedCity News
Fri, 01/14/22 - 11:22 am
Tags:
AstraZeneca, Scorpion Therapeutics, cancer, small molecule drugs
After nabbing two AI-generated molecules, AstraZeneca returns to BenevolentAI with new collaboration
Endpoints
Fri, 01/14/22 - 11:12 am
Tags:
AstraZeneca, BenevolentAI, machine learning, artificial intelligence
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
Tags:
M&A, biotech, Amylyx Pharmaceuticals, Arena Pharmaceuticals, AstraZeneca, Aurinia Pharmaceuticals, Biogen, Biohaven, Bristol Myers Squibb, Eli Lilly, GSK, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi
7 drugs likely to hit $1B in annual revenue in the next 5 years
Beckers Hospital Review
Thu, 01/13/22 - 07:31 am
Tags:
FDA, adagrasib, donanemab, faricimab, lecanemab, tezepelumab, tirzepatide, vutrisiran, Eli Lilly, Mirati Therapeutics, Roche, Chugai, Eisai, Biogen, AstraZeneca, Amgen, Alnylam
JPM22, Day 3: BeiGene, Ionis promise 'tidal wave' of new drugs; Roche launches smart, point-of-care glucose monitor
Fierce Biotech
Wed, 01/12/22 - 11:12 am
Tags:
JPMHC 2022, BeiGene, Ionis Pharmaceuticals, Roche, devices, AstraZeneca, Biogen
AstraZeneca and Neurimmune to develop investigational human monoclonal antibody NI006
Biopharma Reporter
Mon, 01/10/22 - 11:43 am
Tags:
Alexion, AstraZeneca, Neurimmune, NI006, ATTR-CM
AstraZeneca goes bigger in amyloidosis with Neurimmune deal
Pharmaforum
Fri, 01/7/22 - 10:33 am
Tags:
AstraZeneca, ATTR, Neurimmune, NI006

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.